Chrysemys picta bellii isolate RCT428 chromosome 18, Chrysemys_picta_BioNano-3.0.4, whole genome shotgun sequence.
Chrysemys picta bellii (western painted turtle)
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Archelosauria; Testudinata; Testudines; Cryptodira; Durocryptodira; Testudinoidea; Emydidae; Chrysemys.
Physical Mapping and Refinement of the Painted Turtle Genome (Chrysemys picta) Inform Amniote Genome Evolution and Challenge Turtle-Bird Chromosomal Conservation
REFSEQ INFORMATION: The reference sequence is identical to\nCM024787.1.\nAssembly name: Chrysemys_picta_BioNano-3.0.4\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Painted turtle genome\nsequencing consortium on 2020/08/21. The original whole-genome\nshotgun project has the accession AHGY00000000.3.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Painted turtle genome sequencing\n consortium\nAssembly Method :: Newbler v. 2.6\nAssembly Name :: Chrysemys_picta_BioNano-3.0.4\nGenome Coverage :: 19.2x\nSequencing Technology :: 454 Life Sciences\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Chrysemys picta Annotation Release\n 103\nAnnotation Version :: 103\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
small lake 1.3 miles south of Potholes Reservoir
Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 48 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
POU domain, class 3, transcription factor 1
UTP11 small subunit processome component
COORDINATES: polyA evidence [ECO:0006239]
probable U3 small nucleolar RNA-associated protein 11
uncharacterized LOC122174059, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC122174059, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC101936365, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC101936365, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
inositol polyphosphate-5-phosphatase B, transcript variant X2
inositol polyphosphate-5-phosphatase B, transcript variant X4
inositol polyphosphate-5-phosphatase B, transcript variant X1
inositol polyphosphate-5-phosphatase B, transcript variant X5
inositol polyphosphate-5-phosphatase B, transcript variant X3
type II inositol 1,4,5-trisphosphate 5-phosphatase isoform X2
type II inositol 1,4,5-trisphosphate 5-phosphatase isoform X1
type II inositol 1,4,5-trisphosphate 5-phosphatase isoform X4
type II inositol 1,4,5-trisphosphate 5-phosphatase isoform X3
type II inositol 1,4,5-trisphosphate 5-phosphatase isoform X5
inositol polyphosphate-5-phosphatase B, transcript variant X6
type II inositol 1,4,5-trisphosphate 5-phosphatase isoform X6
uncharacterized LOC122174060, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC122174060, transcript variant X2
yrdC N6-threonylcarbamoyltransferase domain containing, transcript variant X2
yrdC N6-threonylcarbamoyltransferase domain containing, transcript variant X3
yrdC N6-threonylcarbamoyltransferase domain containing, transcript variant X1
yrdC domain-containing protein, mitochondrial isoform X2
yrdC domain-containing protein, mitochondrial isoform X3
yrdC domain-containing protein, mitochondrial isoform X1
glycoprotein endo-alpha-1,2-mannosidase-like protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized protein C1orf109 homolog
G protein nucleolar 2, transcript variant X2
G protein nucleolar 2, transcript variant X1
nucleolar GTP-binding protein 2 isoform X1
nucleolar GTP-binding protein 2 isoform X2
dynein axonemal light intermediate chain 1
axonemal dynein light intermediate polypeptide 1
MYST/Esa1 associated factor 6, transcript variant X3
MYST/Esa1 associated factor 6, transcript variant X1
MYST/Esa1 associated factor 6, transcript variant X4
MYST/Esa1 associated factor 6, transcript variant X2
chromatin modification-related protein MEAF6 isoform X1
chromatin modification-related protein MEAF6 isoform X2
zinc finger CCCH-type containing 12A, transcript variant X1
zinc finger CCCH-type containing 12A, transcript variant X3
zinc finger CCCH-type containing 12A, transcript variant X2
glutamate ionotropic receptor kainate type subunit 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
glutamate ionotropic receptor kainate type subunit 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 126 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
glutamate receptor ionotropic, kainate 3
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00015
colony stimulating factor 3 receptor, transcript variant X1
colony stimulating factor 3 receptor, transcript variant X2
granulocyte colony-stimulating factor receptor
mitochondrial ribosomal protein S15, transcript variant X1
mitochondrial ribosomal protein S15, transcript variant X2
28S ribosomal protein S15, mitochondrial
cornifelin homolog B-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 65 samples with support for all annotated introns
cornifelin homolog B-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 68 samples with support for all annotated introns
organic solute carrier partner 1, transcript variant X2
organic solute carrier partner 1, transcript variant X1
LSM10, U7 small nuclear RNA associated, transcript variant X1
LSM10, U7 small nuclear RNA associated, transcript variant X2
LSM10, U7 small nuclear RNA associated, transcript variant X3
U7 snRNA-associated Sm-like protein LSm10
serine/threonine kinase 40, transcript variant X2
serine/threonine kinase 40, transcript variant X1
serine/threonine kinase 40, transcript variant X3
thyroid hormone receptor associated protein 3, transcript variant X1
thyroid hormone receptor associated protein 3, transcript variant X2
thyroid hormone receptor associated protein 3, transcript variant X5
thyroid hormone receptor associated protein 3, transcript variant X6
thyroid hormone receptor associated protein 3, transcript variant X4
thyroid hormone receptor associated protein 3, transcript variant X3
thyroid hormone receptor-associated protein 3
MAP7 domain containing 1, transcript variant X5
MAP7 domain containing 1, transcript variant X4
MAP7 domain containing 1, transcript variant X2
MAP7 domain containing 1, transcript variant X3
MAP7 domain containing 1, transcript variant X1
MAP7 domain-containing protein 1 isoform X5
MAP7 domain-containing protein 1 isoform X4
MAP7 domain-containing protein 1 isoform X2
MAP7 domain-containing protein 1 isoform X3
MAP7 domain-containing protein 1 isoform X1
probable beta-D-xylosidase 2, transcript variant X3
probable beta-D-xylosidase 2, transcript variant X1
probable beta-D-xylosidase 2, transcript variant X2
angiopoietin-2-like, transcript variant X2
angiopoietin-2-like, transcript variant X1
trafficking protein particle complex subunit 3, transcript variant X1
trafficking protein particle complex subunit 3 isoform X1
trafficking protein particle complex subunit 3, transcript variant X2
trafficking protein particle complex subunit 3 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
collagen type VIII alpha 2 chain, transcript variant X1
collagen type VIII alpha 2 chain, transcript variant X3
collagen type VIII alpha 2 chain, transcript variant X4
collagen type VIII alpha 2 chain, transcript variant X2
collagen type VIII alpha 2 chain, transcript variant X5
argonaute RISC catalytic component 3, transcript variant X4
argonaute RISC catalytic component 3, transcript variant X2
argonaute RISC catalytic component 3, transcript variant X1
argonaute RISC catalytic component 3, transcript variant X6
argonaute RISC catalytic component 3, transcript variant X3
argonaute RISC catalytic component 3, transcript variant X5
protein argonaute-1, transcript variant X1
protein argonaute-1, transcript variant X2
protein argonaute-4, transcript variant X2
protein argonaute-4, transcript variant X3
protein argonaute-4, transcript variant X1
protein argonaute-4, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
chromosome 18 C1orf216 homolog, transcript variant X1
chromosome 18 C1orf216 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
transcription factor AP-2 epsilon, transcript variant X3
transcription factor AP-2 epsilon, transcript variant X4
transcription factor AP-2 epsilon, transcript variant X2
transcription factor AP-2 epsilon, transcript variant X1
transcription factor AP-2 epsilon, transcript variant X5
transcription factor AP-2 epsilon, transcript variant X6
transcription factor AP-2-epsilon isoform X2
transcription factor AP-2-epsilon isoform X1
transcription factor AP-2-epsilon isoform X4
transcription factor AP-2-epsilon isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
dyslexia-associated protein KIAA0319-like protein homolog isoform X1
dyslexia-associated protein KIAA0319-like protein homolog isoform X2
interferon alpha-inducible protein 27-like protein 2A, transcript variant X7
interferon alpha-inducible protein 27-like protein 2A isoform X2
interferon alpha-inducible protein 27-like protein 2A, transcript variant X5
interferon alpha-inducible protein 27-like protein 2A, transcript variant X2
interferon alpha-inducible protein 27-like protein 2A, transcript variant X3
interferon alpha-inducible protein 27-like protein 2A, transcript variant X1
interferon alpha-inducible protein 27-like protein 2A, transcript variant X4
interferon alpha-inducible protein 27-like protein 2A, transcript variant X6
interferon alpha-inducible protein 27-like protein 2B isoform X1
zinc finger MYM-type protein 4, transcript variant X1
zinc finger MYM-type protein 4, transcript variant X2
zinc finger MYM-type protein 4, transcript variant X5
zinc finger MYM-type protein 4, transcript variant X4
zinc finger MYM-type protein 4, transcript variant X3
zinc finger MYM-type protein 4, transcript variant X6
zinc finger MYM-type protein 4 isoform X2
zinc finger MYM-type protein 4 isoform X3
zinc finger MYM-type protein 4 isoform X1
zinc finger MYM-type protein 4, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
zinc finger MYM-type protein 4 isoform X4
zinc finger MYM-type protein 4, transcript variant X8
zinc finger MYM-type protein 4 isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
splicing factor proline and glutamine rich, transcript variant X3
splicing factor proline and glutamine rich, transcript variant X2
splicing factor proline and glutamine rich, transcript variant X6
splicing factor proline and glutamine rich, transcript variant X5
splicing factor proline and glutamine rich, transcript variant X4
splicing factor proline and glutamine rich, transcript variant X7
splicing factor proline and glutamine rich, transcript variant X8
splicing factor proline and glutamine rich, transcript variant X1
splicing factor, proline- and glutamine-rich isoform X2
splicing factor, proline- and glutamine-rich isoform X1
platelet-activating factor receptor-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
DLG associated protein 3, transcript variant X1
DLG associated protein 3, transcript variant X2
disks large-associated protein 3 isoform X1
disks large-associated protein 3 isoform X2
small integral membrane protein 12, transcript variant X1
small integral membrane protein 12, transcript variant X2
small integral membrane protein 12, transcript variant X3
small integral membrane protein 12, transcript variant X4
gap junction beta-5 protein-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 48 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
gap junction beta-5 protein-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 48 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: CUB and sushi domain-containing protein 2
regulating synaptic membrane exocytosis 3, transcript variant X2
regulating synaptic membrane exocytosis 3, transcript variant X1
regulating synaptic membrane exocytosis protein 3
nuclear transcription factor Y subunit gamma, transcript variant X2
nuclear transcription factor Y subunit gamma, transcript variant X1
nuclear transcription factor Y subunit gamma
potassium voltage-gated channel subfamily Q member 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
potassium voltage-gated channel subfamily KQT member 4
tubulointerstitial nephritis antigen like 1, transcript variant X1
tubulointerstitial nephritis antigen like 1, transcript variant X2
tubulointerstitial nephritis antigen-like
collagen type XVI alpha 1 chain, transcript variant X5
collagen type XVI alpha 1 chain, transcript variant X4
collagen type XVI alpha 1 chain, transcript variant X2
collagen type XVI alpha 1 chain, transcript variant X3
collagen type XVI alpha 1 chain, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
SPOC domain containing 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
SPOC domain containing 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
SPOC domain containing 1, transcript variant X1
SPOC domain containing 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
SPOC domain containing 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
SPOC domain-containing protein 1 isoform X2
SPOC domain-containing protein 1 isoform X1
SPOC domain-containing protein 1 isoform X3
SPOC domain-containing protein 1 isoform X4
ring finger protein 207, transcript variant X2
ring finger protein 207, transcript variant X1
ring finger protein 207, transcript variant X4
ring finger protein 207, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
ring finger protein 207, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
ring finger protein 207, transcript variant X6
chromodomain helicase DNA binding protein 5, transcript variant X2
chromodomain helicase DNA binding protein 5, transcript variant X1
chromodomain helicase DNA binding protein 5, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
chromodomain-helicase-DNA-binding protein 5 isoform X1
chromodomain-helicase-DNA-binding protein 5 isoform X2
potassium voltage-gated channel subfamily A regulatory beta subunit 2, transcript variant X3
potassium voltage-gated channel subfamily A regulatory beta subunit 2, transcript variant X6
potassium voltage-gated channel subfamily A regulatory beta subunit 2, transcript variant X2
potassium voltage-gated channel subfamily A regulatory beta subunit 2, transcript variant X4
potassium voltage-gated channel subfamily A regulatory beta subunit 2, transcript variant X5
potassium voltage-gated channel subfamily A regulatory beta subunit 2, transcript variant X7
potassium voltage-gated channel subfamily A regulatory beta subunit 2, transcript variant X1
voltage-gated potassium channel subunit beta-2 isoform X3
voltage-gated potassium channel subunit beta-2 isoform X2
voltage-gated potassium channel subunit beta-2 isoform X4
voltage-gated potassium channel subunit beta-2 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
adherens junctions associated protein 1, transcript variant X3
adherens junctions associated protein 1, transcript variant X4
adherens junction-associated protein 1 isoform X4
adherens junction-associated protein 1 isoform X3
adherens junctions associated protein 1, transcript variant X2
adherens junctions associated protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
adherens junction-associated protein 1 isoform X2
adherens junction-associated protein 1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
chromosome 18 C1orf174 homolog, transcript variant X1
UPF0688 protein C1orf174 homolog isoform X1
chromosome 18 C1orf174 homolog, transcript variant X2
UPF0688 protein C1orf174 homolog isoform X2
centrosomal protein 104, transcript variant X5
centrosomal protein 104, transcript variant X2
centrosomal protein 104, transcript variant X6
centrosomal protein 104, transcript variant X3
centrosomal protein 104, transcript variant X4
centrosomal protein 104, transcript variant X1
centrosomal protein of 104 kDa isoform X1
centrosomal protein of 104 kDa isoform X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: leucine-rich repeat-containing protein 47
small integral membrane protein 1 (Vel blood group), transcript variant X3
small integral membrane protein 1 (Vel blood group), transcript variant X1
small integral membrane protein 1 (Vel blood group), transcript variant X2
coiled-coil domain containing 27, transcript variant X2
coiled-coil domain containing 27, transcript variant X3
coiled-coil domain containing 27, transcript variant X6
coiled-coil domain containing 27, transcript variant X4
coiled-coil domain containing 27, transcript variant X1
coiled-coil domain containing 27, transcript variant X5
coiled-coil domain-containing protein 27 isoform X2
coiled-coil domain-containing protein 27 isoform X5
coiled-coil domain-containing protein 27 isoform X3
coiled-coil domain-containing protein 27 isoform X1
coiled-coil domain-containing protein 27 isoform X4
uncharacterized protein LOC101938923 isoform X1
inositol 2-dehydrogenase-like, transcript variant X3
inositol 2-dehydrogenase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 45 samples with support for all annotated introns
inositol 2-dehydrogenase-like, transcript variant X1
uncharacterized protein LOC101939375 isoform X1
uncharacterized protein LOC101939375 isoform X3
inositol 2-dehydrogenase-like isoform X2
tumor protein p73, transcript variant X1
tumor protein p73, transcript variant X6
tumor protein p73, transcript variant X3
tumor protein p73, transcript variant X2
tumor protein p73, transcript variant X4
tumor protein p73, transcript variant X5
tumor protein p73, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 66 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
tumor protein p73, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 66 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
tumor protein p63-regulated gene 1-like protein
multiple EGF like domains 6, transcript variant X3
multiple EGF like domains 6, transcript variant X2
multiple EGF like domains 6, transcript variant X1
multiple epidermal growth factor-like domains protein 6
Rho guanine nucleotide exchange factor 16
PR/SET domain 16, transcript variant X12
PR/SET domain 16, transcript variant X13
PR/SET domain 16, transcript variant X10
PR/SET domain 16, transcript variant X11
histone-lysine N-methyltransferase PRDM16 isoform X4
histone-lysine N-methyltransferase PRDM16 isoform X3
histone-lysine N-methyltransferase PRDM16 isoform X2
histone-lysine N-methyltransferase PRDM16 isoform X1
histone-lysine N-methyltransferase PRDM16 isoform X5
histone-lysine N-methyltransferase PRDM16 isoform X6
histone-lysine N-methyltransferase PRDM16 isoform X8
histone-lysine N-methyltransferase PRDM16 isoform X9
histone-lysine N-methyltransferase PRDM16 isoform X10
histone-lysine N-methyltransferase PRDM16 isoform X11
histone-lysine N-methyltransferase PRDM16 isoform X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 317 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 671 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 166 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 308 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
membrane metalloendopeptidase like 1, transcript variant X3
membrane metalloendopeptidase like 1, transcript variant X2
membrane metalloendopeptidase like 1, transcript variant X1
membrane metallo-endopeptidase-like 1 isoform X1
membrane metallo-endopeptidase-like 1 isoform X2
membrane metallo-endopeptidase-like 1 isoform X3
tumor necrosis factor receptor superfamily member 5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 72 samples with support for all annotated introns
tumor necrosis factor receptor superfamily member 14-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122174066, transcript variant X2
uncharacterized LOC122174066, transcript variant X1
probable glutamate receptor, transcript variant X1
probable glutamate receptor, transcript variant X2
probable glutamate receptor, transcript variant X3
phospholipase C eta 2, transcript variant X1
phospholipase C eta 2, transcript variant X2
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2 isoform X2
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2 isoform X1
peroxisomal biogenesis factor 10, transcript variant X1
peroxisomal biogenesis factor 10, transcript variant X2
peroxisomal biogenesis factor 10, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
peroxisome biogenesis factor 10 isoform X1
peroxisome biogenesis factor 10 isoform X2
retention in endoplasmic reticulum sorting receptor 1
MORN repeat containing 1, transcript variant X3
MORN repeat containing 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
MORN repeat containing 1, transcript variant X1
MORN repeat containing 1, transcript variant X6
MORN repeat containing 1, transcript variant X4
MORN repeat-containing protein 1 isoform X4
MORN repeat-containing protein 1 isoform X3
MORN repeat-containing protein 1 isoform X1
MORN repeat containing 1, transcript variant X2
MORN repeat-containing protein 1 isoform X2
MORN repeat-containing protein 1 isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
enoyl-CoA delta isomerase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 49 samples with support for all annotated introns
enoyl-CoA delta isomerase 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 51 samples with support for all annotated introns
enoyl-CoA delta isomerase 1, transcript variant X1
enoyl-CoA delta isomerase 1, mitochondrial isoform X3
enoyl-CoA delta isomerase 1, mitochondrial isoform X1
enoyl-CoA delta isomerase 1, mitochondrial isoform X2
deoxyribonuclease 1 like 2, transcript variant X4
deoxyribonuclease 1 like 2, transcript variant X1
deoxyribonuclease 1 like 2, transcript variant X2
deoxyribonuclease 1 like 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
N-alpha-acetyltransferase 60, NatF catalytic subunit, transcript variant X2
N-alpha-acetyltransferase 60, NatF catalytic subunit, transcript variant X1
N-alpha-acetyltransferase 60, NatF catalytic subunit, transcript variant X3
nudix hydrolase 16 like 1, transcript variant X2
nudix hydrolase 16 like 1, transcript variant X1
tudor-interacting repair regulator protein isoform X2
tudor-interacting repair regulator protein isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
mahogunin ring finger 1, transcript variant X1
E3 ubiquitin-protein ligase MGRN1 isoform X1
mahogunin ring finger 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 53 samples with support for all annotated introns
mahogunin ring finger 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 64 samples with support for all annotated introns
mahogunin ring finger 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 74 samples with support for all annotated introns
E3 ubiquitin-protein ligase MGRN1 isoform X4
E3 ubiquitin-protein ligase MGRN1 isoform X3
E3 ubiquitin-protein ligase MGRN1 isoform X2
UBA like domain containing 1, transcript variant X2
UBA like domain containing 1, transcript variant X1
UBA-like domain-containing protein 1 isoform X1
UBA-like domain-containing protein 1 isoform X2
cell death-inducing p53-target protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
zinc finger protein 501-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
zinc finger protein 501-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
zinc finger protein 501-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
zinc finger protein 501-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
zinc finger protein 501-like, transcript variant X3
zinc finger protein 501-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
zinc finger protein 501-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 58 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: zinc finger protein 501-like
zinc finger protein 239-like, transcript variant X2
zinc finger protein 239-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
zinc finger protein 239-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
zinc finger protein 239-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
zinc finger protein 239-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
SLX4 structure-specific endonuclease subunit, transcript variant X7
SLX4 structure-specific endonuclease subunit, transcript variant X6
SLX4 structure-specific endonuclease subunit, transcript variant X5
SLX4 structure-specific endonuclease subunit, transcript variant X1
SLX4 structure-specific endonuclease subunit, transcript variant X4
SLX4 structure-specific endonuclease subunit, transcript variant X3
SLX4 structure-specific endonuclease subunit, transcript variant X2
structure-specific endonuclease subunit SLX4 isoform X4
structure-specific endonuclease subunit SLX4 isoform X3
structure-specific endonuclease subunit SLX4 isoform X2
structure-specific endonuclease subunit SLX4 isoform X1
heat shock protein 75 kDa, mitochondrial
CREB binding protein, transcript variant X4
CREB binding protein, transcript variant X5
CREB binding protein, transcript variant X2
CREB binding protein, transcript variant X8
CREB binding protein, transcript variant X7
CREB binding protein, transcript variant X3
CREB binding protein, transcript variant X6
CREB binding protein, transcript variant X1
adenylate cyclase 9, transcript variant X5
adenylate cyclase 9, transcript variant X4
adenylate cyclase 9, transcript variant X3
adenylate cyclase 9, transcript variant X1
adenylate cyclase 9, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
transcription factor AP-4, transcript variant X2
transcription factor AP-4, transcript variant X3
transcription factor AP-4, transcript variant X1
GLIS family zinc finger 2, transcript variant X1
GLIS family zinc finger 2, transcript variant X4
GLIS family zinc finger 2, transcript variant X5
GLIS family zinc finger 2, transcript variant X3
GLIS family zinc finger 2, transcript variant X2
presequence translocase associated motor 16
mitochondrial import inner membrane translocase subunit TIM16
DnaJ heat shock protein family (Hsp40) member A3, transcript variant X1
DnaJ heat shock protein family (Hsp40) member A3, transcript variant X2
dnaJ homolog subfamily A member 3, mitochondrial isoform X2
dnaJ homolog subfamily A member 3, mitochondrial isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
NLR family CARD domain-containing protein 3
clusterin associated protein 1, transcript variant X4
clusterin associated protein 1, transcript variant X2
clusterin associated protein 1, transcript variant X1
clusterin associated protein 1, transcript variant X3
clusterin-associated protein 1 isoform X3
clusterin-associated protein 1 isoform X1
clusterin-associated protein 1 isoform X2
clusterin-associated protein 1 isoform X4
ankyrin repeat and sterile alpha motif domain containing 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
ankyrin repeat and sterile alpha motif domain containing 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
ankyrin repeat and sterile alpha motif domain containing 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
ankyrin repeat and sterile alpha motif domain containing 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ankyrin repeat and SAM domain-containing protein 3 isoform X1
ankyrin repeat and SAM domain-containing protein 3 isoform X2
NME/NM23 nucleoside diphosphate kinase 4
nucleoside diphosphate kinase, mitochondrial
2,4-dienoyl-CoA reductase 2, transcript variant X2
2,4-dienoyl-CoA reductase 2, transcript variant X1
peroxisomal 2,4-dienoyl-CoA reductase [(3E)-enoyl-CoA-producing] isoform X1
peroxisomal 2,4-dienoyl-CoA reductase [(3E)-enoyl-CoA-producing] isoform X2
2,4-dienoyl-CoA reductase 2, transcript variant X3
2,4-dienoyl-CoA reductase 2, transcript variant X4
2,4-dienoyl-CoA reductase 2, transcript variant X5
2,4-dienoyl-CoA reductase 2, transcript variant X6
peroxisomal 2,4-dienoyl-CoA reductase [(3E)-enoyl-CoA-producing] isoform X3
peroxisomal 2,4-dienoyl-CoA reductase [(3E)-enoyl-CoA-producing] isoform X4
RAB11 family interacting protein 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
RAB11 family interacting protein 3, transcript variant X1
RAB11 family interacting protein 3, transcript variant X2
rab11 family-interacting protein 3 isoform X1
rab11 family-interacting protein 3 isoform X2
rab11 family-interacting protein 3 isoform X3
RAB11 family interacting protein 3, transcript variant X4
rab11 family-interacting protein 3 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
phosphatidylinositol glycan anchor biosynthesis class Q, transcript variant X3
phosphatidylinositol glycan anchor biosynthesis class Q, transcript variant X2
phosphatidylinositol glycan anchor biosynthesis class Q, transcript variant X1
phosphatidylinositol N-acetylglucosaminyltransferase subunit Q isoform X1
phosphatidylinositol glycan anchor biosynthesis class Q, transcript variant X4
phosphatidylinositol N-acetylglucosaminyltransferase subunit Q isoform X2
RAB40C, member RAS oncogene family, transcript variant X1
RAB40C, member RAS oncogene family, transcript variant X2
WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 1
WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1
methyltransferase like 26, transcript variant X2
methyltransferase like 26, transcript variant X1
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA glycine (anticodon CCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 32% coverage of the annotated genomic feature by RNAseq alignments
MAPK regulated corepressor interacting protein 2, transcript variant X4
MAPK regulated corepressor interacting protein 2, transcript variant X1
MAPK regulated corepressor interacting protein 2, transcript variant X2
MAPK regulated corepressor interacting protein 2, transcript variant X3
MAPK regulated corepressor interacting protein 2 isoform X1
MAPK regulated corepressor interacting protein 2 isoform X3
MAPK regulated corepressor interacting protein 2 isoform X4
MAPK regulated corepressor interacting protein 2 isoform X2
ATP binding cassette subfamily A member 3, transcript variant X6
ATP binding cassette subfamily A member 3, transcript variant X5
ATP binding cassette subfamily A member 3, transcript variant X3
ATP binding cassette subfamily A member 3, transcript variant X2
ATP binding cassette subfamily A member 3, transcript variant X1
ATP binding cassette subfamily A member 3, transcript variant X4
phospholipid-transporting ATPase ABCA3 isoform X2
phospholipid-transporting ATPase ABCA3 isoform X3
phospholipid-transporting ATPase ABCA3 isoform X1
ankyrin repeat and fibronectin type-III domain-containing protein 1-like, transcript variant X3
ankyrin repeat and fibronectin type-III domain-containing protein 1-like, transcript variant X5
ankyrin repeat and fibronectin type-III domain-containing protein 1-like, transcript variant X1
ankyrin repeat and fibronectin type-III domain-containing protein 1-like, transcript variant X6
ankyrin repeat and fibronectin type-III domain-containing protein 1-like, transcript variant X11
ankyrin repeat and fibronectin type-III domain-containing protein 1-like, transcript variant X12
ankyrin repeat and fibronectin type-III domain-containing protein 1-like, transcript variant X13
ankyrin repeat and fibronectin type-III domain-containing protein 1-like, transcript variant X2
ankyrin repeat and fibronectin type-III domain-containing protein 1-like, transcript variant X10
ankyrin repeat and fibronectin type-III domain-containing protein 1-like, transcript variant X14
ankyrin repeat and fibronectin type-III domain-containing protein 1-like, transcript variant X4
ankyrin repeat and fibronectin type-III domain-containing protein 1-like, transcript variant X9
ankyrin repeat and fibronectin type-III domain-containing protein 1-like isoform X1
ankyrin repeat and fibronectin type-III domain-containing protein 1-like isoform X2
ankyrin repeat and fibronectin type-III domain-containing protein 1-like isoform X4
ankyrin repeat and fibronectin type-III domain-containing protein 1-like isoform X5
ankyrin repeat and fibronectin type-III domain-containing protein 1-like isoform X6
ankyrin repeat and fibronectin type-III domain-containing protein 1-like, transcript variant X7
ankyrin repeat and fibronectin type-III domain-containing protein 1-like, transcript variant X8
ankyrin repeat and fibronectin type-III domain-containing protein 1-like isoform X3
ankyrin repeat and fibronectin type-III domain-containing protein 1-like isoform X7
ankyrin repeat and fibronectin type-III domain-containing protein 1-like, transcript variant X15
ankyrin repeat and fibronectin type-III domain-containing protein 1-like, transcript variant X16
ankyrin repeat and fibronectin type-III domain-containing protein 1-like isoform X8
ankyrin repeat and fibronectin type-III domain-containing protein 1-like isoform X9
ankyrin repeat and fibronectin type-III domain-containing protein 1-like, transcript variant X18
ankyrin repeat and fibronectin type-III domain-containing protein 1-like, transcript variant X19
ankyrin repeat and fibronectin type-III domain-containing protein 1-like, transcript variant X17
ankyrin repeat and fibronectin type-III domain-containing protein 1-like, transcript variant X20
ankyrin repeat and fibronectin type-III domain-containing protein 1-like isoform X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 54 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns